Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging

S Chawla, S Kim, LA Loevner… - American journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Patients with HNSCC have a poor prognosis and
development of imaging biomarkers that predict long-term outcome might aid in planning …

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases

A Shukla-Dave, NY Lee, JFA Jansen, HT Thaler… - International Journal of …, 2012 - Elsevier
PURPOSE: Dynamic contrast-enhanced MRI (DCE-MRI) can provide information regarding
tumor perfusion and permeability and has shown prognostic value in certain tumors types …

Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging

S Kim, LA Loevner, H Quon, A Kilger… - American journal …, 2010 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Tumor microenvironment, including blood flow and
permeability, may provide crucial information regarding response to chemoradiation …

T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma

AD King, CK Keung, KH Yu, FKF Mo… - American Journal …, 2013 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: T2-weighted MRI shows potential in early posttreatment
assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar …

[HTML][HTML] DCE-MRI for pre-treatment prediction and post-treatment assessment of treatment response in sites of squamous cell carcinoma in the head and neck

AD King, SKK Chow, KH Yu, FKF Mo, DKW Yeung… - PLoS …, 2015 - journals.plos.org
Background and Purpose It is important to identify patients with head and neck squamous
cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo …

Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) …

S Alfieri, R Romanò, M Bologna, G Calareso… - Acta …, 2021 - Taylor & Francis
Objectives To identify and validate baseline magnetic resonance imaging (b-MRI) radiomic
features (RFs) as predictors of disease outcomes in effectively cured head and neck …

Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck

S Chawla, S Kim, L Dougherty… - American Journal of …, 2013 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to predict response to chemoradiation therapy
in patients with head and neck squamous cell carcinoma (HNSCC) by combined use of …

[HTML][HTML] Predictive value of diffusion-weighted imaging without and with including contrast-enhanced magnetic resonance imaging in image analysis of head and neck …

DP Noij, PJW Pouwels, R Ljumanovic, DL Knol… - European journal of …, 2015 - Elsevier
Objectives To assess disease-free survival (DFS) in head and neck squamous cell
carcinoma (HNSCC) treated with (chemo) radiotherapy ([C] RT). Methods Pretreatment MR …

[HTML][HTML] Value of dynamic contrast-enhanced MRI to detect local tumor recurrence in primary head and neck cancer patients

YJ Choi, JH Lee, YS Sung, RG Yoon, JE Park, SY Nam… - Medicine, 2016 - journals.lww.com
Abstract Treatment failures in head and neck cancer patients are mainly related to
locoregional tumor recurrence. The objective of the present study was to evaluate the …

Normalized parameters of dynamic contrast-enhanced perfusion MRI and DWI-ADC for differentiation between posttreatment changes and recurrence in head and …

A Baba, R Kurokawa, E Rawie… - American Journal …, 2022 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Differentiating recurrence from benign posttreatment
changes has clinical importance in the imaging follow-up of head and neck cancer. This …